z-logo
open-access-imgOpen Access
Can Routine Commercial Cord Blood Banking Be Scientifically and Ethically Justified?
Author(s) -
Nicholas M. Fisk,
Irene Roberts,
Roger R. Markwald,
Vladimir Mironov
Publication year - 2005
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.0020044
Subject(s) - cord blood , umbilical cord , medicine , placenta , haematopoiesis , transplantation , obstetrics , bone marrow , placenta cord banking , stem cell , pregnancy , intensive care medicine , immunology , surgery , fetus , biology , genetics
Background to the debate: Umbilical cord blood—the blood that remains in the placenta after birth—can be collected and stored frozen for years. A well-accepted use of cord blood is as an alternative to bone marrow as a source of hematopoietic stem cells for allogeneic transplantation to siblings or to unrelated recipients; women can donate cord blood for unrelated recipients to public banks. However, private banks are now open that offer expectant parents the option to pay a fee for the chance to store cord blood for possible future use by that same child (autologous transplantation.)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom